RE: Worth a reminder9 Jul 2020 20:29
Milcait, I agree with you. Awacta have churned out a number of interviews and videos stating what they're doing and aiming for. The company has been very firm that it will succeed and bring these tests to market.
It would be bizarre for the company to go to such lengths to set themselves up for a massive failure. The long term damage to the companies value would be signicant as all trust would be lost in the CEO. I know many will point out this is AIM etc etc, but Sir Al does not strike me as a shady character who's out to mislead people. His message has been clear the whole way through and has not changed. There's been no backtracking or anything along those lines.
I know people are still talking about the placing and previously being supposedly 'fully funded,' but he took the opportunity to secure the future of the company whilst bringing a very dilligent hedge fund on board at £1.20 when they could've bought in at 20p only a number of weeks beforehand.
People who are against the placing and still going on about it are basically suggesting that you don't need a lot of money to bring whats likely to be one of the planets most in demand products to market, whilst simultaneously working on revolutionising cancer treatments. Yes, there was clearly a leak but there's no way of knowing whether than came from Awacta. It probably didn't in my opinion and therefore has no reflection on the company.